What Researchers Did
Researchers evaluated the effect of hyperbaric oxygenation treatment (HBO) on donor morbidity in 14 living donor liver transplantation (LDLT) donors, comparing an HBO group (n=7) to a control group (n=7).
What They Found
The incidence of wound numbness on postoperative day (POD) 28 was significantly lower in the HBO group (29%, 2/7) compared to the control group (86%, 6/7) (p<0.05). On POD 14, the HBO group showed significantly lower AST and total bilirubin levels, higher PT%, and higher albumin levels on POD 7, 10, and 28 (all p<0.05).
What This Means for Canadian Patients
Canadian patients undergoing living donor liver transplantation might experience reduced postoperative complications like wound numbness and improved liver function markers if treated with hyperbaric oxygen. This could potentially lead to a more comfortable and smoother recovery period for donors.
Canadian Relevance
There is no direct Canadian connection mentioned in the study metadata or abstract.
Study Limitations
A significant limitation of this study is the very small sample size of only 14 donors, which limits the generalizability of the findings.